Amaryl 1mg, 2mg, 3mg and 4mg Tablets
Last Updated on eMC 05-Nov-2013 View document | Zentiva Contact details
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 05-Nov-2013 and displayed until Current
Reasons for adding or updating:
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - use in children/adolescents
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 2 - driving and using machines
- Change to section 2 - excipient warnings
- Change to section 4 - possible side effects
- Change to section 4 - how to report a side effect
Updated on 18-Jul-2013 and displayed until 05-Nov-2013
Reasons for adding or updating:
- Change to section 6 - what the product looks like and pack contents
Updated on 21-Sep-2012 and displayed until 18-Jul-2013
Reasons for adding or updating:
- New PIL for new product
Zentiva
One Onslow Street, Guildford, Surrey, GU1 4YS
+44 (0) 1483 554831
+44 (0)1483 505 515
+44 (0)845 372 7101
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue